205 related articles for article (PubMed ID: 2471546)
1. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
MacKie RM; White SI; Seywright MM; Young H
Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
Di Gregorio C; Losi L; Annessi G; Botticelli A
Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
[TBL] [Abstract][Full Text] [Related]
4. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
Rose DS
J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
[TBL] [Abstract][Full Text] [Related]
5. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
Leong AS; Gilham P
Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
Evans AT; Orrell JM; Grant A
J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study.
Crocker J; Skilbeck N
J Clin Pathol; 1987 Aug; 40(8):885-9. PubMed ID: 3654987
[TBL] [Abstract][Full Text] [Related]
8. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
Naik R; Raghuveer CV; Jacob DL
J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
[TBL] [Abstract][Full Text] [Related]
9. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
Gonzalez AP; Kumar D; Sánchez RL
Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
[TBL] [Abstract][Full Text] [Related]
10. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
Howat AJ; Wright AL; Cotton DW; Reeve S
Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
[TBL] [Abstract][Full Text] [Related]
11. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
Fallowfield ME; Cook MG
Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar organizer regions in melanocytic dysplasia and melanoma.
Fallowfield ME; Dodson AR; Cook MG
Histopathology; 1988 Jul; 13(1):95-9. PubMed ID: 3209193
[TBL] [Abstract][Full Text] [Related]
13. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
14. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
Orrell JM; Evans AT; Grant A
J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
Reis JP; Tellechea O; Baptista AP
Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
[TBL] [Abstract][Full Text] [Related]
16. Nuclear and cytoplasmic features in the diagnosis of banal nevi, Spitz nevi, and melanoma.
Valdebran M; Elbendary A; Chaitanya Arudra SK; Torres KM; Elattar I; Elston DM
J Am Acad Dermatol; 2016 Nov; 75(5):1032-1037.e8. PubMed ID: 27542585
[TBL] [Abstract][Full Text] [Related]
17. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.
Mackie RM; Campbell I; Turbitt ML
J Clin Pathol; 1984 Apr; 37(4):367-72. PubMed ID: 6200506
[TBL] [Abstract][Full Text] [Related]
18. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
[TBL] [Abstract][Full Text] [Related]
19. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural study of superficial spreading melanoma and benign simulants.
Mintzis MM; Silvers DN
Cancer; 1978 Aug; 42(2):502-11. PubMed ID: 679152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
